Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic

OBJECTIVE: No data are available to develop uniform recommendations for reperfusion therapies in ST-segment elevation myocardial infarction (STEMI) during the coronavirus disease 2019 (COVID-19) pandemic. We aimed to fill the evidence gap regarding STEMI reperfusion strategy during the COVID-19 era....

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Int Med Res
Main Authors: Wang, Nan, Zhang, Min, Su, Huajun, Huang, Zhonglue, Lin, Yongbo
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2020
Teme:
Retrospective Clinical Research Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7645389/
https://ncbi.nlm.nih.gov/pubmed/33108941
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0300060520966151
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki